Research programme: needle-free injection delivered drugs - Glide Technologies/UndisclosedAlternative Names: GP 51
Latest Information Update: 16 May 2015
At a glance
- Originator Glide Pharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 01 Mar 2013 No development reported - Preclinical for Undefined indication in United Kingdom (SC)